Form 4: Orchestra BioMed Holdings Principal Accounting Officer Aiello Reports Share Withholding for Tax Obligations
SEC Form 4 Filing
Principal Accounting Officer Joshua Aiello reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 26, 2025, Joshua Aiello, Principal Accounting Officer of Orchestra BioMed Holdings, Inc., had 278 common shares withheld by the issuer to satisfy tax obligations related to the vesting of restricted stock units.
- The price per share was $4.38.
- Following the transaction, Aiello beneficially owns 4,722 common shares directly.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a standard transaction (share withholding for tax obligations). It doesn't inherently convey positive or negative sentiment.
Management Comments
- No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.
Industry Context
This is a standard Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency into insider transactions.
Key Dates
| Date | Description |
|---|---|
| 03/26/2025 | Date of transaction: Share withholding for tax obligations. |
| 03/28/2025 | Date of signature by Attorney-in-Fact. |
Keywords
Form 4, Orchestra BioMed Holdings, Joshua Aiello, Share Withholding, Tax Obligations, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.